Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Chief Financial Officer sold 8,246 shares at $1.31 ($10,802)
  4. 4 Open-market sale President and CEO sold 13,853 shares at $1.30 ($18,009)
  5. 4 Grant or award Chief Financial Officer acquired 34,200 shares (grant or award)
  6. 4 Grant or award S.V.P., General Counsel acquired 34,200 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 56,700 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy 10% owner bought 1,000,000 shares at $1.70 ($1,700,000)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Pres & CEO acquired 125,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award S.V.P., General Counsel acquired 75,000 shares (grant or award)

Page 13 of 23 · 459 filings